Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients.
Journal article

Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients.

  • Saad, Fred University of Montreal, Montreal, QC, Canada
  • Carles, Joan Vall d'Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain
  • Gillessen, Silke Kantonsspital St. Gallen, St. Gallen, Switzerland
  • Heinrich, Daniel Akershus University Hospital, Lørenskog, Norway
  • Gratt, Jeremy Bayer HealthCare, Whippany, NJ
  • Miller, Kurt Charité University Medicine Berlin, Berlin, Germany
  • Nilsson, Sten Karolinska University Hospital, Stockholm, Sweden
  • O'Sullivan, Joe Centre for Cancer Research and Cell Biology, Queen's University Belfast and the Northern Ireland Cancer Centre, Belfast, Northern Ireland
  • Tucci, Marcello Department of Oncology, San Luigi Hospital, Orbassano (Turin), Italy
  • Wirth, Manfred University Hospital Carl Gustav Carus, Dresden, Germany
  • Heidenreich, Axel University Hospital, RWTH Aachen, Aachen, Germany
Show more…
Published in:
  • Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2015, vol. 33, no. 15_suppl, p. 5034-5034
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/93240
Statistics

Document views: 41 File downloads: